Clinical Trial

Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)

Study acronym: DIPLOMA-3
Recruiting
View on ClinicalTrials.gov →
Summary
The DIPLOMA-3 trial is an international, multicenter, patient-blinded randomized controlled trial comparing laparoscopic and robot-assisted left-sided pancreatectomy. Patients with an indication for elective left-sided pancreatecomy for benign or premalignant lesions in the body or tail of the pancreas and considered eligible will be randomized between laparoscopic and robot-assisted resection.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-15.
Status change: Not Yet Recruiting → Recruiting 2025-08-28
Trial Details
NCT Number NCT06939023
Lead Sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborators: Leiden University Medical Center, Catharina Ziekenhuis Eindhoven, Erasmus Medical Center, Medisch Spectrum Twente, Maastricht University Medical Center, University Medical Center Groningen, Onze Lieve Vrouwe Gasthuis
Conditions Pancreatectomy, Distal Pancreatectomy (DP), Pancreatic Neoplasms, Pancreatic Adenoma, Pancreatic Cyst, Pancreatic Cystadenoma, Surgery, Minimally Invasive Surgical Technique +2 more
Enrollment 256 participants
Start Date 2025-06-01
Primary Completion 2027-06-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-04